beta

VTRS

Viatris Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

mylan is a global pharmaceutical company committed to setting new standards in healthcare. working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. we offer a growing portfolio of around 1,400 generic pharmaceuticals and several brand medications. in addition, we offer a wide range of antiretroviral therapies, upon which nearly 50% of hiv/aids patients in developing countries depend. we also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time. learn more at mylan.com.

Market Cap: 14.5 Billion

Primary Exchange: NASDAQ

Website: mylan.com

Shares Outstanding: 1.19 Billion

Float: 0

Dividend: 0.46542634024626106 (0.04%)

Beta: 0.8142914882246406

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 276 trading days

From: 2020-11-19 To: 2024-03-07

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2023-03-08 2023-03-17 2023-03-09 2023-02-24 0.12 Cash
2023-05-23 2023-06-16 2023-05-24 2023-05-05 0.12 Cash
2023-08-23 2023-09-15 2023-08-24 2023-08-04 0.12 Cash
2023-11-22 2023-12-15 2023-11-24 2023-11-07 0.12 Cash
2024-03-08 2024-03-18 2024-03-11 2024-02-26 0.12 Cash
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud